These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30084190)

  • 21. Does Renal Denervation a Reasonable Treatment Option in Hemodialysis-Dependent Patient with Resistant Hypertension? A Narrative Review.
    Mazza A; Dell'Avvocata F; Torin G; Bulighin F; Battaglia Y; Fiorini F
    Curr Hypertens Rep; 2023 Nov; 25(11):353-363. PubMed ID: 37672130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low dialysate sodium levels for chronic haemodialysis.
    Dunlop JL; Vandal AC; Marshall MR
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD011204. PubMed ID: 30646428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Managing dry weight and hypertension in dialysis patients: still a challenge for the nephrologist in 2009?
    Chazot C
    J Nephrol; 2009; 22(5):587-97. PubMed ID: 19809991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Chen YJ; Li LJ; Tang WL; Song JY; Qiu R; Li Q; Xue H; Wright JM
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008170. PubMed ID: 30480768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology, Pathophysiology, and Clinical Perspectives of Intradialytic Hypertension.
    Theofilis P; Vordoni A; Kalaitzidis RG
    Am J Nephrol; 2023; 54(5-6):200-207. PubMed ID: 37231809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of low versus high dialysate sodium concentration on blood pressure and endothelial-derived vasoregulators during hemodialysis: a randomized crossover study.
    Inrig JK; Molina C; D'Silva K; Kim C; Van Buren P; Allen JD; Toto R
    Am J Kidney Dis; 2015 Mar; 65(3):464-73. PubMed ID: 25530107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2017 May; 35(5):922-944. PubMed ID: 28141660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of dry-weight reduction guided by lung ultrasound on ambulatory blood pressure in hemodialysis patients: a randomized controlled trial.
    Loutradis C; Sarafidis PA; Ekart R; Papadopoulos C; Sachpekidis V; Alexandrou ME; Papadopoulou D; Efstratiadis G; Papagianni A; London G; Zoccali C
    Kidney Int; 2019 Jun; 95(6):1505-1513. PubMed ID: 31027889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment and Management of Hypertension among Patients on Peritoneal Dialysis.
    Vaios V; Georgianos PI; Liakopoulos V; Agarwal R
    Clin J Am Soc Nephrol; 2019 Feb; 14(2):297-305. PubMed ID: 30341090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
    Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
    Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antihypertensive Medications in End-Stage Renal Disease.
    Denker MG; Cohen DL
    Semin Dial; 2015; 28(4):330-6. PubMed ID: 25877881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology, diagnosis and management of hypertension among patients on chronic dialysis.
    Georgianos PI; Agarwal R
    Nat Rev Nephrol; 2016 Oct; 12(10):636-47. PubMed ID: 27573731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Timing of Antihypertensive Medications on Key Outcomes in Hemodialysis: A Cluster Randomized Trial.
    Chang TI; Tatoian ET; Montez-Rath ME; Chertow GM
    Kidney360; 2021 Nov; 2(11):1752-1760. PubMed ID: 35373003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The controversies of diagnosing and treating hypertension among hemodialysis patients.
    Agarwal R
    Semin Dial; 2012 Jul; 25(4):370-6. PubMed ID: 22686564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers.
    Verdecchia P; Gentile G; Angeli F; Reboldi G
    Ther Adv Cardiovasc Dis; 2012 Apr; 6(2):81-91. PubMed ID: 22528743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intradialytic hypertension: a less-recognized cardiovascular complication of hemodialysis.
    Inrig JK
    Am J Kidney Dis; 2010 Mar; 55(3):580-9. PubMed ID: 19853337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW; Laugerotte A; Wright JM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antihypertensive medications and risk of death and hospitalizations in US hemodialysis patients: Evidence from a cohort study to inform hypertension treatment practices.
    Shafi T; Sozio SM; Luly J; Bandeen-Roche KJ; St Peter WL; Ephraim PL; McDermott A; Herzog CA; Crews DC; Scialla JJ; Tangri N; Miskulin DC; Michels WM; Jaar BG; Zager PG; Meyer KB; Wu AW; Boulware LE;
    Medicine (Baltimore); 2017 Feb; 96(5):e5924. PubMed ID: 28151871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
    Hackam DG; Khan NA; Hemmelgarn BR; Rabkin SW; Touyz RM; Campbell NR; Padwal R; Campbell TS; Lindsay MP; Hill MD; Quinn RR; Mahon JL; Herman RJ; Schiffrin EL; Ruzicka M; Larochelle P; Feldman RD; Lebel M; Poirier L; Arnold JM; Moe GW; Howlett JG; Trudeau L; Bacon SL; Petrella RJ; Milot A; Stone JA; Drouin D; Boulanger JM; Sharma M; Hamet P; Fodor G; Dresser GK; Carruthers SG; Pylypchuk G; Burgess ED; Burns KD; Vallée M; Prasad GV; Gilbert RE; Leiter LA; Jones C; Ogilvie RI; Woo V; McFarlane PA; Hegele RA; Tobe SW;
    Can J Cardiol; 2010 May; 26(5):249-58. PubMed ID: 20485689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.